ATE305053T1 - Für den von willebrand faktor der hunde kodierende dna und verfahren zu ihrer verwendung - Google Patents

Für den von willebrand faktor der hunde kodierende dna und verfahren zu ihrer verwendung

Info

Publication number
ATE305053T1
ATE305053T1 AT97933549T AT97933549T ATE305053T1 AT E305053 T1 ATE305053 T1 AT E305053T1 AT 97933549 T AT97933549 T AT 97933549T AT 97933549 T AT97933549 T AT 97933549T AT E305053 T1 ATE305053 T1 AT E305053T1
Authority
AT
Austria
Prior art keywords
von willebrand
willebrand factor
dna coding
dog
coding dog
Prior art date
Application number
AT97933549T
Other languages
English (en)
Inventor
Patrick J Venta
George J Brewer
Vilma Yuzbasiyan-Gurkan
William D Schall
Original Assignee
Univ Michigan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21801758&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE305053(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Michigan filed Critical Univ Michigan
Application granted granted Critical
Publication of ATE305053T1 publication Critical patent/ATE305053T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT97933549T 1996-07-19 1997-07-18 Für den von willebrand faktor der hunde kodierende dna und verfahren zu ihrer verwendung ATE305053T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2099896P 1996-07-19 1996-07-19
PCT/US1997/012606 WO1998003683A1 (en) 1996-07-19 1997-07-18 Dna encoding canine von willebrand factor and methods of use

Publications (1)

Publication Number Publication Date
ATE305053T1 true ATE305053T1 (de) 2005-10-15

Family

ID=21801758

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97933549T ATE305053T1 (de) 1996-07-19 1997-07-18 Für den von willebrand faktor der hunde kodierende dna und verfahren zu ihrer verwendung

Country Status (7)

Country Link
US (1) US6040143A (de)
EP (1) EP0961836B1 (de)
AT (1) ATE305053T1 (de)
AU (1) AU3671197A (de)
CA (1) CA2261015C (de)
DE (1) DE69734247T2 (de)
WO (1) WO1998003683A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6074832A (en) * 1996-07-19 2000-06-13 The Regents Of The University Of Michigan DNA encoding canine von Willebrand factor and methods of use
US6767707B2 (en) * 1996-07-19 2004-07-27 University Of Michigan DNA encoding canine von willebrand factor and methods of use
US6780583B1 (en) 1996-07-19 2004-08-24 Board Of Trustees Operating Michigan State University DNA encoding canine von willebrand factor and methods of use
US6410237B1 (en) 1997-07-18 2002-06-25 Board Of Trustees Operating Michigan State University DNA encoding canine von Willebrand factor and methods of use
CA2341896A1 (en) 1998-08-28 2000-03-09 Febit Ferrarius Biotechnology Gmbh Support for a method for determining an analyte and a method for producing the support
DE10051396A1 (de) 2000-10-17 2002-04-18 Febit Ferrarius Biotech Gmbh Verfahren und Vorrichtung zur integrierten Synthese und Analytbestimmung an einem Träger
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
KR20070101227A (ko) 2004-09-07 2007-10-16 아케믹스 코포레이션 폰 빌레브란트 인자에 대한 앱타머 및 이의 혈전증치료제로서의 용도
JP2008512097A (ja) * 2004-09-07 2008-04-24 アーケミックス コーポレイション アプタマー医薬品化学
US20090203766A1 (en) * 2007-06-01 2009-08-13 Archemix Corp. vWF aptamer formulations and methods for use
CN105816858B (zh) 2007-12-28 2024-10-18 武田药品工业株式会社 重组vwf配方
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
EP2349314B1 (de) * 2008-10-21 2013-02-27 Baxter International Inc. Lyophilisierte rekombinante vwf-formulierungen
KR101808751B1 (ko) 2009-11-13 2017-12-13 그리폴스 테라퓨틱스 인코포레이티드 폰 빌레브란트 인자(ｖＷＦ)-함유 제제, 및 그와 관련된 방법, 키트 및 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8500961A (nl) * 1985-04-01 1986-11-03 Stichting Vrienden Van De Stic Cdna-codering voor de humane von willebrand-factor, plasmiden met een dergelijke cdna-codering respektievelijk fragmenten ervan, alsmede micro-organismen, welke dergelijke plasmiden bevatten.
GB9422814D0 (en) * 1994-11-11 1995-01-04 Medinnova Sf Chemical method

Also Published As

Publication number Publication date
CA2261015A1 (en) 1998-01-29
EP0961836A4 (de) 2000-05-03
AU3671197A (en) 1998-02-10
DE69734247D1 (de) 2006-02-02
EP0961836B1 (de) 2005-09-21
US6040143A (en) 2000-03-21
CA2261015C (en) 2001-12-25
DE69734247T2 (de) 2006-06-22
EP0961836A1 (de) 1999-12-08
WO1998003683A1 (en) 1998-01-29

Similar Documents

Publication Publication Date Title
ATE305053T1 (de) Für den von willebrand faktor der hunde kodierende dna und verfahren zu ihrer verwendung
DE3675567D1 (de) Verstaerkte kautschukmischungen, verfahren zu ihrer herstellung und ihre verwendung.
DE3679292D1 (de) Perlfoermige vernetzte, epoxy- und basische aminogruppen aufweisende mischpolymerisate, verfahren zu ihrer herstellung und ihre verwendung.
DE68925083D1 (de) Rekombinante DNS, diese rekombinante DNS enthaltender Mikroorganismus und Verfahren zur Herstellung von L-Aminosäure unter Verwendung dieses Mikroorganismus
ATE125255T1 (de) Decahydroisoquinolin-derivate, verfahren zu ihrer herstellung und ihre verwendung als medikamente.
DE69627314D1 (de) Kettenabbruchgruppen, ihre verwendung zur sequenzierung und synthese von nukleinsäuren und verfahren zu ihrer herstellung
DE3677048D1 (de) Katalysator zur herstellung von aromatischen kohlenwasserstoffen und verfahren zur herstellung aromatischer kohlenwasserstoffe unter verwendung dieses katalysators.
DE3688209D1 (de) Verfahren zur herstellung von kohlenstoffilamenten und durch dieses verfahren erhaltene kohlenstoffilamente.
DE69511779D1 (de) Lumineszenzdioden-Anordnung und Verfahren zu ihrer Herstellung
ATE206131T1 (de) Phosphonomonoesternnukleinsäuren, verfahren zu ihrer herstellung und ihre verwendung
ATA141786A (de) Verfahren zur herstellung von neuen peptid-verbindungen und ihrer salze
DE3687103D1 (de) Verfahren zur herstellung von n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline.
DE69516116D1 (de) Sequenzierung von nukleinsäuren
DE69606242D1 (de) Verfahren zur herstellung von fällungskieselsäure, zink-enthaltende fällungskieselsäuren und verwendung zur verstärkung von elastomeren
DE3765043D1 (de) Verfahren zum herstellen von geschnittenen straengen aus kohlenstoffasern und solche straenge.
DE69823372D1 (de) Verfahren und reagentiensatz zur amplifizierung, sequenzierung und typisierung von hla i genen
ATE221537T1 (de) Neue (alpha-aminophosphino) peptide, verfahren zu ihrer herstellung und ihre therapeutische verwendung
PT86380A (de) 2,3-disubstituierte isoxazolidine verfahren zu ihrer herstellung diese enthaltende mittel und ihre verwendung
DE3650676D1 (de) Verfahren und mittel zur sortierung und bestimmung biologischer informationen
ATE156118T1 (de) Verfahren zur herstellung von fibrinogen-rezeptor-antagonisten
PT83239A (de) Aminosaeure-derivate verfahren zu ihrer herstellung und verwendung
DE68913890D1 (de) Verfahren zur züchtung tierischer zellen in grossem massstab und verfahren zur herstellung von trägermaterial dafür.
DE58900220D1 (de) Rhodium-katalysatoren, verfahren zu ihrer herstellung und verfahren zur herstellung von gegebenenfalls substituiertem diphenylamin unter einsatz der rhodium-katalysatoren.
DE69318559D1 (de) Peptide brauchbar als microsequezierungsstandard und verfahren zu ihrer anwendung
ATE60359T1 (de) Menschlicher b-zellen-differenzierungsfaktor und verfahren zu dessen herstellung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties